| DDO-3055 / Jiangsu Hengrui Pharma |
NCT04197778: Food Effect Study of DDO-3055 Tablets in Healthy Subjects |
|
|
| Completed | 1 | 14 | RoW | DDO-3055 tablet | Jiangsu HengRui Medicine Co., Ltd. | Anemia in Chronic Kidney Disease | 01/20 | 01/20 | | |
NCT03976115: A Study to Evaluate the Safety and Efficacy of DDO-3055 in Healthy Volunteers and Patients With Chronic Kidney Disease |
|
|
| Completed | 1 | 54 | RoW | DDO-3055, Placebos | Jiangsu HengRui Medicine Co., Ltd. | Chronic Kidney Disease | 05/21 | 05/21 | | |
NCT04775615: Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Healthy Subjects. |
|
|
| Not yet recruiting | 1 | 36 | NA | DDO-3055 tablets；Placebo | Jiangsu HengRui Medicine Co., Ltd. | Renal Anemia | 05/21 | 06/21 | | |
NCT04470063: Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Patients With Anemia of Non-dialysis Chronic Kidney Diseases. |
|
|
| Enrolling by invitation | 1 | 30 | RoW | DDO-3055 tablets, Placebo | Jiangsu HengRui Medicine Co., Ltd. | Anemia Associated Chronic Kidney Disease | 12/21 | 12/21 | | |
